Pharmacoeconomic analysis of adjuvant oral capecitabine vs intravenous 5-FU/LV in Dukes' C colon cancer - the X-ACT trial

Results

Naziv:	Pharmacoeconomic analysis of adjuvant oral capecitabine vs intravenous 5-FU/LV in Dukes' C colon cancer - the X-ACT trial
Autori:	Cassidy, J.; Douillard, Y.; Twelves, C.; McKendrick, J. J.; Scheithauer, W.; Bustova, I.; Johnston, P. G.; Lesniewski-Kmak, L.; Jelić, Svetislav ; Fountzilas, G.; Coxon, F.; Diaz-Rubio, E.; Maughan, T. S.; Malzyner, A.; Bertetto, O.; Beham, A.; Figer, A.; Dufour, P.; Patel, K. K.; Cowell, W.; Garrison, L. P.;
Godina:	2006
Publikacija:	British Journal of Cancer
ISSN:	0007-0920 British Journal of Cancer Pretraži identifikator
Izdavač:	Houndmills : H Holt MacMillan Journals
Tip rezultata:	Naučni članak
Kolacija:	vol. 94 br. 8 str. 1122-1129
DOI:	10.1038/sj.bjc.6603059
WoS-ID:	000236910300006
Scopus-ID:	2-s2.0-33646142547
PMID:	16622438
PMCID:	PMC2361258
VBS COBISS:	1026712757
URI:	https://plus.cobiss.net/cobiss/sr/sr/bib/1026712757#izum.si https://enauka.gov.rs/handle/123456789/645569
M-kategorija:	21M21 - Vodeći međunarodni časopis kategorije M21

116
SCOPUS^TM

45
PubMed Central^TM

83
OpenCitations

98
WEB OF SCIENCE^TM

Altmetric

Dimensions

Unpaywall